Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Amneal Pharmaceuticals Logo
Amneal Pharmaceuticals Growth Score
70
CB Rank
17960
Heat Score
81
Amneal Pharmaceuticals is a pharmaceutical company that develops, generic medicines, specialty pharmaceuticals, and biosimilars.
Founded
obfuscation
PublicPost-IPO Debt Bridgewater, New Jersey, United States5001-10000 amneal.com/
Manufacturing
Medical
Pharmaceutical
Overview

Amneal Pharmaceuticals
Total Funding
obfuscation
Growth Score
70
Heat Score
81

Total Funding
obfuscation
obfuscation
Post-IPO Debt raised
obfuscation
Growth Score70
-9 pts
in past quarter
Heat Score 81
15 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+4 more milestones
See more interactive data and historical milestones on desktop for the best experience

About Amneal Pharmaceuticals

CB Rank
17960
Amneal Pharmaceuticals is a pharmaceutical company that develops, generic medicines, specialty pharmaceuticals, and biosimilars.
Founded
obfuscation
PublicPost-IPO Debt Bridgewater, New Jersey, United States5001-10000 amneal.com/
Manufacturing
Medical
Pharmaceutical

Funding Rounds

Post-IPO Debt
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation
Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Legal Name Amneal Pharmaceuticals LLC
Operating Status Active
Stock Symbol  NYSE:AMRX
Company Type For Profit
Founders  Chintu Patel, Chirag Patel
About the Company
Amneal is much more than just a company. It is a remarkable collection of dynamic and innovative people dedicated to the constant pursuit of excellence.
Phone Number (908) 947-3120
Contact Email sales@amneal.com
Predictions & Insights

Growth Insight

See this Growth Insight
Amneal Pharmaceuticals is
Lorem
 to be growing
Top Contributing Factors
Financial Growth

Products & Services

Generic Pharmaceuticals
A portfolio of over 280 generic medicines providing affordable access to essential drugs in the U.S. market.
Specialty Pharmaceuticals
Branded pharmaceutical products focused on central nervous system and endocrine disorders.

Research & Development

Amneal Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
...

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Amneal Pharmaceuticals Logo
Post-IPO Debt - Amneal Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Amneal Pharmaceuticals Logo
Post-IPO Debt - Amneal Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Amneal Pharmaceuticals Logo
Post-IPO Debt - Amneal Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Amneal Pharmaceuticals Logo
Post-IPO Debt - Amneal Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Amneal Pharmaceuticals Logo
Post-IPO Debt - Amneal Pharmaceuticals
—
obfuscation
— Post-IPO Debt

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Debt - Amneal Pharmaceuticals Logo
Post-IPO Debt - Amneal Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Amneal Pharmaceuticals Logo
Post-IPO Debt - Amneal Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Amneal Pharmaceuticals Logo
Post-IPO Debt - Amneal Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Amneal Pharmaceuticals Logo
Post-IPO Debt - Amneal Pharmaceuticals
—
obfuscation
— Post-IPO Debt
obfuscation
Post-IPO Debt - Amneal Pharmaceuticals Logo
Post-IPO Debt - Amneal Pharmaceuticals
—
obfuscation
— Post-IPO Debt

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Fidelity Logo
Fidelity
—
Post-IPO Equity - Amneal Pharmaceuticals Logo
Post-IPO Equity - Amneal Pharmaceuticals
—
Fidelity Logo
Fidelity
—
Post-IPO Equity - Amneal Pharmaceuticals Logo
Post-IPO Equity - Amneal Pharmaceuticals
—
Fidelity Logo
Fidelity
—
Post-IPO Equity - Amneal Pharmaceuticals Logo
Post-IPO Equity - Amneal Pharmaceuticals
—
Fidelity Logo
Fidelity
—
Post-IPO Equity - Amneal Pharmaceuticals Logo
Post-IPO Equity - Amneal Pharmaceuticals
—
Fidelity Logo
Fidelity
—
Post-IPO Equity - Amneal Pharmaceuticals Logo
Post-IPO Equity - Amneal Pharmaceuticals
—

Investments

Number of Acquisitions 7

Investment Breakdown

Number of Acquisitions 7
Market Intelligence
People
View Profiles & Contacts
Headcount 5001-10000 Employee Profiles 17 Board Members and Advisors 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 9, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 5, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 4, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

37,293
78.36%
 in past month

IT Spend

$220.1MThis year, Amneal Pharmaceuticals is projected to spend $220.1M on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Hybrid IT Environments Logo
Hybrid IT Environments
100
Acer Logo
Acer
100
Test Data Management Logo
Test Data Management
100

Actively Used Products

11Amneal Pharmaceuticals uses 11 technology products and services including HTML5, Lightbox, and  GlobalSign, according to G2 Stack.

Active Website Tech Count

44Amneal Pharmaceuticals is actively using 44 technologies for its website, according to BuiltWith. These include HSTS, DNSSEC, and  nginx.

Total IP

110The intellectual property of Amneal Pharmaceuticals includes 73 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery. Additionally, Amneal Pharmaceuticals has registered 37 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Amneal Pharmaceuticals's headquarters? Amneal Pharmaceuticals is located in Bridgewater, New Jersey, United States.Who invested in Amneal Pharmaceuticals? Amneal Pharmaceuticals has 3 investors including Fidelity and  TPG.When was the last funding round for Amneal Pharmaceuticals? Amneal Pharmaceuticals closed its last funding round on
obfuscation
from a Post-IPO Debt round.Who are Amneal Pharmaceuticals's competitors? Alternatives and possible competitors to Amneal Pharmaceuticals may include Kashiv BioSciences, Alto Neuroscience, and  Amgen.How much funding has Amneal Pharmaceuticals raised to date? Amneal Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(250d0b0 1)
|